Drug Approvals
🇺🇸 FDA Page 42FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 493–504 of 665 articles
FDA Approves First Non-Antipsychotic for Dementia Agitation
FDA Approves Incyte's Jakafi XR Extended-Release Tablets for Myelofibrosis, Polycythemia Vera Treatment
Auvelity FDA Approval: New MDD Treatment Option
ANVISA Regulatory Changes: Key Impact on Foreign Drug Manufacturers in Brazil
ANVISA Approves New Cannabis Framework & MagicTouch Device: Market Impact
COFEPRIS Drug Approvals 2026: What You Need to Know
ANVISA Clinical Trial Regulations: What Foreign Pharma Must Know in 2025
Plozasiran TGA Approval: REDEMPLO® Now Available in Australia for FCS
Rhythm Pharmaceuticals' IMCIVREE Receives European Commission Approval for Acquired Hypothalamic Obesity
Novo Nordisk's Oral Ozempic Becomes First FDA-Approved Pill GLP-1 for Type 2 Diabetes with Cardiovascular Protection
Axsome Therapeutics Receives FDA Approval for AUVELITY to Treat Alzheimer's Agitation - First-in-Class Breakthrough
Arvinas Receives FDA Approval for VEPPANU (Vepdegestrant), First PROTAC Drug for ESR1-Mutated Breast Cancer